Efficacy of high-intensity aerobic exercise on common multiple sclerosis symptoms.

Fatigue and walking difficulty are among the most disabling symptoms of multiple sclerosis, and clinicians have limited tools to address them directly. This trial asked whether a structured, supervised program of progressive aerobic exercise, done twice weekly for 24 weeks, could ease these symptoms compared with a waitlist group who kept their usual routines before later doing the same program. People who exercised reported less fatigue impact on daily life, with the improvement large enough to be considered clinically relevant by the researchers' own threshold, and their fitness levels rose measurably. Walking ability and walking distance showed only small, uncertain improvements, and measures of fatigue severity, quick walking speed, and quality of life did not change.

The authors note their findings need confirming in future research given the study's limitations, meaning this encouraging signal on fatigue should be read as preliminary rather than settled.

If you live with multiple sclerosis, fatigue and walking trouble are probably familiar frustrations, and it's natural to wonder whether exercise actually helps or just feels like one more demand on limited energy. This study followed people with MS who were randomly assigned to either a supervised aerobic exercise program, done twice a week for 24 weeks at a fairly vigorous pace, or to continue their usual routine first and start the program later. The people who exercised reported meaningfully less impact from fatigue on their daily lives, and their fitness improved.

Walking distance and ease showed only small, uncertain improvements, and other measures, including fatigue severity ratings, a timed walking test, and quality of life, did not show clear change. This was one trial, and the researchers themselves say the results need confirming in future studies before firm conclusions can be drawn. It's a hopeful early finding about fatigue specifically, not proof that exercise changes every MS symptom.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This randomised controlled trial addresses a practical question physiotherapists face regularly: does structured aerobic exercise meaningfully reduce fatigue and improve walking in people with MS, or do self-reported gains reflect something other than a true physiological effect? Eighty-six people with MS were randomised to 24 weeks of supervised progressive aerobic exercise (two sessions weekly, 30-60 minutes at 65-95% maximum heart rate) followed by self-guided activity, or to 24 weeks of habitual lifestyle followed by the same exercise program, with intention-to-treat analysis across both crossover periods. The primary fatigue outcome (Modified Fatigue Impact Scale total) showed a between-group reduction of 5.3 points (95% CI -10.9 to 0.4), with the point estimate exceeding the authors' clinical relevance threshold, alongside significant improvements on physical and psychosocial subscores and a VO2 max increase of 3.5 ml O2/min/kg. Walking scale and six-minute walk test differences were small and the confidence intervals crossed zero, suggesting the walking signal is uncertain rather than a confirmed effect; fatigue severity, the Six Spot Step Test, and quality of life showed no detected difference between groups. The waitlist comparator received no attention-matched control, so some of the self-reported fatigue benefit could partly reflect participation or expectation effects rather than the exercise itself.

The authors explicitly state the findings require confirmation in a future trial given study limitations, so this should inform rather than settle clinical reasoning about aerobic exercise prescription for MS fatigue.